Skip to content
The COVID Project
  1. Library
  2. Other federal health agencies
  3. AGY-FED-HEALTH-OTHER-023

Ex. AGY-FED-HEALTH-OTHER-023 Context (guidance or announcement) Primary source read

DEA-DC-052 (EO-DEA183), guidance: Using a home address as the principal place of business or professional practice

Using a Home Address as the Principal Place of Business or Professional Practice

Drug Enforcement Administration, Diversion Control Division (guidance document EO-DEA183) · United States (federal); Drug Enforcement Administration, Diversion Control Division (Federal)

The COVID Project
Context, not an order

This record is guidance or an announcement kept for context. It is not counted among the orders in force.

The record

Jurisdiction
United States (federal); Drug Enforcement Administration, Diversion Control Division
Level
Federal
Authority
21 U.S.C. 822(e); 21 C.F.R. 1301.12
Issued
2021-07-08 July 8, 2021
Effective
2021-07-08
End
In force (revised Nov. 2021) (read as 2021-09-30)
In force
July 8, 2021 to Sept. 30, 2021
Quarters
2021 Q3
Limitation types
Telework mandateHealth care ordersOther
Addressees
  • DEA-registered individual practitioners
Functions reached
  • OF office and telework
  • TM telehealth
Character
context
Collection
Other federal health agencies AGY-FED-HEALTH-OTHER

Operative words

Question: Can an individual practitioner use their home address as the principal place of business or professional practice? Answer: Yes.

Enforcement

Registration requirements under 21 U.S.C. 822 and 842

Notes

Q3 2021 instrument accommodating practitioners who dispensed and prescribed from home under continuing remote-practice arrangements.

Retrieval note

Cite it as context and cite the underlying order, statute or emergency rule it describes as the instrument. (Bulletins whose operative text imposes a mandatory duty on licensees under the regulator's own authority are excluded from this downgrade and listed separately for review.)).